Doravirine 100 Mg: Clinical Trials

2 trials of Doravirine 100 Mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Phase 41Completed 1

Follow Doravirine 100 Mg: new trials by email Literature Review of Doravirine 100 Mg trials Research Report on Doravirine 100 Mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Doravirine 100 Mg - HIV I Infection, Cardiovascular Risk Factor
Early Phase 1CompletedUniversity of Texas Southwestern Medical Center262024-03-012026-01-30
Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide
Doravirine 100 Mg, Integrase strand transfer inhibitors, Tenofovir alafenamide/emtricitabine - HIV Infections
Phase 4CompletedAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1472021-07-272025-07-02

Conditions studied

Cardiovascular Diseases (1)  ·  HIV Infections (1)  ·  Lipid Metabolism Disorders (1)

Sponsors

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (2)

Top investigators

John Koethe (1)  ·  Theodoros Kelesidis, MD PHD (1)

Results publications

PMID 41847923

NIH funding

UM1AI068636 (1)